跳至主要内容
临床试验/JPRN-UMIN000041205
JPRN-UMIN000041205已完成未知

A retrospective study to evaluate the predictive ability of a DNA methylation status-based diagnostic method for the sensitivity of anti-EGFR treatment in metastatic colorectal cancer - Observational study on a method for predicting the efficacy of anti-EGFR treatment for colorectal cancer

Institute of Development, Aging and Cancer (IDAC), Tohoku University0 个研究点目标入组 241 人开始时间: 2020年7月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
241

研究概览

简要总结

DNA methylation status may be a predictor of therapeutic response to anti-EGFR antibody drugs in the first-line treatment of metastatic colorectal cancer.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who received anti-EGFR antibodies in the first or second line of treatment. Cases in which the patient is unable to submit the required amount of tissue samples from the primary tumor for measurement of methylation status. Cases considered by the attending physician to be unsuitable for enrollment in this study.

研究者

发起方
Institute of Development, Aging and Cancer (IDAC), Tohoku University

相似试验

A retrospective study to evaluate the predictive... | 临床试验